Paper36932180
Psychedelics: preclinical insights provide directions for future research.
Gumpper RH and 1 other. Neuropsychopharmacology, 2024. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Psychedelics: preclinical insights provide directions for future research. Papers, record 36932180. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36932180
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics1
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hallucinogens | Major topic |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26,841,800 | Psychedelics. | Pharmacol Rev | 2016 | https://conductscience.org/library/papers/26841800 | PubMed |
| 2 | 35,301,459 | The promises and perils of psychedelic pharmacology for psychiatry. | Nat Rev Drug Discov | 2022 | https://conductscience.org/library/papers/35301459 | PubMed |
| 3 | 27,909,165 | Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. | J Psychopharmacol | 2016 | https://conductscience.org/library/papers/27909165 | PubMed |
| 4 | 27,909,164 | Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. | J Psychopharmacol | 2016 | https://conductscience.org/library/papers/27909164 | PubMed |
| 5 | 33,852,780 | Trial of Psilocybin versus Escitalopram for Depression. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33852780 | PubMed |
| 6 | 36,322,843 | Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. | N Engl J Med | 2022 | https://conductscience.org/library/papers/36322843 | PubMed |
| 8 | 2,943 | LSD as an agonist at mesolimbic dopamine receptors. | Psychopharmacologia | 1975 | https://conductscience.org/library/papers/2943 | PubMed |
| 9 | 3,336,031 | [125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors. | J Med Chem | 1988 | https://conductscience.org/library/papers/3336031 | PubMed |
| 10 | 3,437,942 | Binding to the serotonin 5-HT2 receptor by the enantiomers of 125I-DOI. | Neuropharmacology | 1987 | https://conductscience.org/library/papers/3437942 | PubMed |
| 11 | 25,895,059 | PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. | Nat Struct Mol Biol | 2015 | https://conductscience.org/library/papers/25895059 | PubMed |
| 12 | 5,567,294 | Quipazine, a new type of antidepressant agent. | Psychopharmacologia | 1971 | https://conductscience.org/library/papers/5567294 | PubMed |
| 13 | 6,513,725 | Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. | Life Sci | 1984 | https://conductscience.org/library/papers/6513725 | PubMed |
| 14 | 31,917,152 | Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. | Neuropharmacology | 2020 | https://conductscience.org/library/papers/31917152 | PubMed |
| 15 | 2,843,634 | Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. | J Pharmacol Exp Ther | 1988 | https://conductscience.org/library/papers/2843634 | PubMed |
| 16 | 7,099,138 | [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. | Mol Pharmacol | 1982 | https://conductscience.org/library/papers/7099138 | PubMed |
| 17 | 9,875,725 | Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. | Neuroreport | 1998 | https://conductscience.org/library/papers/9875725 | PubMed |
| 18 | 22,578,254 | Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. | Biol Psychiatry | 2012 | https://conductscience.org/library/papers/22578254 | PubMed |
| 19 | 32,946,782 | Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor. | Cell | 2020 | https://conductscience.org/library/papers/32946782 | PubMed |
| 20 | 36,171,289 | Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity. | Nature | 2022 | https://conductscience.org/library/papers/36171289 | PubMed |
| 21 | 17,270,739 | Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. | Neuron | 2007 | https://conductscience.org/library/papers/17270739 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,828,395 | The Emergence of Isotryptamine Analogs as Novel Serotonergic Agents with Psychotherapeutic Potential. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42828395 | PubMed |
| 40,534,669 | The Selective Serotonin 5‑HT2A Receptor Agonist (S)‑3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40534669 | PubMed |
| 39,900,337 | Molecular Glues: A New Approach to Modulating GPCR Signaling Bias. | Biochemistry | 2025 | https://conductscience.org/library/papers/39900337 | PubMed |
| 39,833,376 | Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/39833376 | PubMed |
| 39,094,057 | Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money. | Annu Rev Psychol | 2025 | https://conductscience.org/library/papers/39094057 | PubMed |
| 38,898,956 | 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review. | ACS Pharmacol Transl Sci | 2024 | https://conductscience.org/library/papers/38898956 | PubMed |
| 38,743,110 | Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties. | Psychopharmacology (Berl) | 2025 | https://conductscience.org/library/papers/38743110 | PubMed |
| 38,340,182 | Effects of congeners of amphetamine on the human heart. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/38340182 | PubMed |
| 38,093,842 | α-Ethyltryptamine: A Ratiocinatory Review of a Forgotten Antidepressant. | ACS Pharmacol Transl Sci | 2023 | https://conductscience.org/library/papers/38093842 | PubMed |
| 38,011,560 | Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/38011560 | PubMed |
| 37,488,282 | Therapeutic mechanisms of psychedelics and entactogens. | Neuropsychopharmacology | 2024 | https://conductscience.org/library/papers/37488282 | PubMed |
| 37,067,459 | G protein-coupled receptors as targets for transformative neuropsychiatric therapeutics. | Am J Physiol Cell Physiol | 2023 | https://conductscience.org/library/papers/37067459 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36932180
GET https://conductscience.org/api/papers/v1/36932180/references?page=2